Autism Mandates: How Insurance Changes Impact Healthcare Spending for Children
"Discover how autism insurance mandates affect healthcare costs and access to care for families, and what it means for your child's treatment."
Autism spectrum disorder (ASD) affects many children, creating substantial challenges for families and healthcare systems. The increasing prevalence of ASD has led states to enact autism insurance mandates, requiring private insurers to cover screening, diagnosis, and treatment. But what happens after these mandates go into effect? How do healthcare expenditures change, and who benefits most?
A recent study published in 'Research in Autism Spectrum Disorders' dives deep into these questions, analyzing seven years of insurance claims data from Pennsylvania, a state that implemented its autism mandate in mid-2009. By comparing healthcare expenditures before and after the mandate, and across different types of insurance plans, the study reveals significant shifts in how autism care is funded and accessed.
This article breaks down the study's findings, offering insights into the real-world effects of autism insurance mandates. Whether you're a parent, healthcare provider, or policy maker, understanding these changes is crucial for ensuring that children with ASD receive the timely and comprehensive care they need.
Healthcare Spending and Access
The AHRQ Medical Expenditure Panel Survey report found that average total health expenditures for children with treated ASD declined with age, while home healthcare accounted for approximately one-third of their average total expenditures. Among children without treated ASD, average expenditures were $1,662 with public-only insurance and $2,579 with any private insurance, a difference the report described as not statistically significant for average total expenditures overall. Research on state insurance mandates found that increases in autism treatment use were larger for younger children and grew with the number of years since mandate implementation, suggesting that mandates can broaden access under commercial insurance.
Claims-Based Evaluation
Studies of autism insurance mandates have used de-identified insurance claims data to compare healthcare expenditures before and after policy changes. One Pennsylvania study analyzed 2006–2012 claims from the state's largest private insurer, where the mandate took effect in mid-2009. Healthcare expenditures were defined as the amount paid by the insurer for healthcare services and adjusted to 2012 price levels; another study notes that, by the time of its publication, 46 states and the District of Columbia had enacted commercial-insurance mandates for children with ASD.
The Autism Mandate Effect: A Closer Look at Healthcare Spending
The Pennsylvania study examined data from 2006 to 2012, focusing on children diagnosed with ASD and continuously enrolled in insurance plans. Researchers looked at total healthcare expenditures (all medical costs) and ASD-related expenditures (costs specifically for autism treatment). By comparing these figures before and after Pennsylvania's mandate, they uncovered some striking trends.
- Large Employer Plans: Experienced the most substantial increase in spending post-mandate.
- Self-Insured Plans: Showed a moderate increase, likely due to voluntary coverage of ASD services by some employers.
- Small Employer and Individual Plans: Saw minimal changes in spending, reflecting their exempt status from the mandate.
- Children's Health Insurance Program (CHIP): Had variable costs due to small sample sizes, with no clear pattern after the mandate.
Rising Employer-Plan Spending
A study of young children with ASD in employer-sponsored plans reported that mean spending per child with a current-year ASD diagnosis increased by 51% in 2017 U.S. dollars. Spending rose from roughly $13,000 in 2011 to $20,000 in 2017. More recent research has examined how insurance gaps relate to healthcare experiences and the financial burden of self-payment among autistic children in the United States, using 2010–2021 Medical Expenditure Panel Survey data and multivariable regression analyses.
Uncaptured Sources of Care
The state-mandate study identified important limits in its spending data. The researchers did not capture services delivered to children in schools or services paid for completely out of pocket by families. Its 2008–2012 study period covered the most active phase of state mandate adoption and included many children observed before and after implementation, but the uncaptured services mean the measured spending did not represent every source of autism care.
Pennsylvania Expenditure Differences
In a Pennsylvania analysis, pre-mandate total expenditures per child with ASD were similar between groups, but post-mandate expenditures rose more sharply for children subject to the autism mandate. Spending increased 87%, from $7,754 in 2008 to $14,486 in 2010, for the mandate-exposed group, compared with a 27% increase, from $7,238 to $9,171, for exempt groups. A national review explains that autism mandates require commercial insurers to cover certain evidence-based ASD treatments, while the benefits covered vary across states.
Policy Implications and Future Directions
The study underscores the significant impact of autism insurance mandates on healthcare spending and access to care. By demonstrating how spending patterns shift after a mandate goes into effect, the findings can inform policy decisions and help ensure that resources are allocated effectively. While the Pennsylvania mandate has led to increased spending and improved access for many children with ASD, disparities remain. Exempt groups, such as those with small employer plans or self-insured plans, may not benefit to the same extent, highlighting the need for further policy adjustments to ensure equitable access to care.